Literature DB >> 10781638

Preconditioning limits myocardial infarct size in hypercholesterolemic rabbits.

D T Kremastinos1, E Bofilis, G K Karavolias, A Papalois, L Kaklamanis, E K Iliodromitis.   

Abstract

BACKGROUND: Hypercholesterolemia predisposes to coronary artery disease and causes endothelial dysfunction; some reports suggest that endothelial derived substances are involved in ischemic preconditioning.
OBJECTIVE: Our aim was to examine the possibility that preconditioning maybe attenuated in a clinically relevant animal model of hypercholesterolemia with atherosclerosis.
METHODS: Male rabbits were fed with cholesterol enriched diet and then divided into two groups (A and B) without and with preconditioning, respectively. A second series of rabbits fed a normal diet were similarly divided into two groups (C and D) without and with preconditioning, respectively. All the animals were subjected to 30 min ischemia and 180 min reperfusion. Blood samples were collected for cholesterol assessment; arterial and heart samples were harvested at the end for histopathological examination. Infarct (I) and risk areas (R) were delineated with Zn-Cd particles and TTC staining.
RESULTS: Cholesterol in groups A and B was 58.3+/-8.7 mg% at baseline and 1402+/-125 mg% at 8 weeks (P<0.0001) and in groups C and D 57.5+/-5.8 mg% before the surgical procedure. I/R% was 39. 3+/-6.3% in group A, 16.7+/-3.9% in B (P<0.01), 41.4+/-7.5% in C and 10.8+/-3.3% in D (P<0.01).
CONCLUSION: We conclude that preconditioning is unlikely to be attenuated by hypercholesterolemia.

Entities:  

Mesh:

Year:  2000        PMID: 10781638     DOI: 10.1016/s0021-9150(99)00389-5

Source DB:  PubMed          Journal:  Atherosclerosis        ISSN: 0021-9150            Impact factor:   5.162


  10 in total

Review 1.  Myocardial ischaemia/reperfusion injury and preconditioning: effects of hypercholesterolaemia/hyperlipidaemia.

Authors:  Péter Ferdinandy
Journal:  Br J Pharmacol       Date:  2003-01       Impact factor: 8.739

Review 2.  Preconditioning: a paradigm shift in the biology of myocardial ischemia.

Authors:  Roberto Bolli
Journal:  Am J Physiol Heart Circ Physiol       Date:  2006-09-08       Impact factor: 4.733

Review 3.  The late phase of preconditioning and its natural clinical application--gene therapy.

Authors:  Roberto Bolli; Qian-Hong Li; Xian-Liang Tang; Yiru Guo; Yu-Ting Xuan; Gregg Rokosh; Buddhadeb Dawn
Journal:  Heart Fail Rev       Date:  2007-12       Impact factor: 4.214

Review 4.  Effect of hypercholesterolaemia on myocardial function, ischaemia-reperfusion injury and cardioprotection by preconditioning, postconditioning and remote conditioning.

Authors:  Ioanna Andreadou; Efstathios K Iliodromitis; Antigone Lazou; Anikó Görbe; Zoltán Giricz; Rainer Schulz; Péter Ferdinandy
Journal:  Br J Pharmacol       Date:  2017-02-08       Impact factor: 8.739

Review 5.  Hyperlipidaemia and cardioprotection: Animal models for translational studies.

Authors:  Ioanna Andreadou; Rainer Schulz; Lina Badimon; Adriana Adameová; Petra Kleinbongard; Sandrine Lecour; Panagiota-Efstathia Nikolaou; Ines Falcão-Pires; Gemma Vilahur; Nicholas Woudberg; Gerd Heusch; Péter Ferdinandy
Journal:  Br J Pharmacol       Date:  2020-01-17       Impact factor: 8.739

6.  Hypercholesterolemia blunts NO donor-induced late preconditioning against myocardial infarction in conscious rabbits.

Authors:  Xian-Liang Tang; Adam B Stein; Gregg Shirk; Roberto Bolli
Journal:  Basic Res Cardiol       Date:  2004-09-16       Impact factor: 17.165

7.  Attenuation of increased myocardial ischaemia-reperfusion injury conferred by hypercholesterolaemia through pharmacological inhibition of the caspase-1 cascade.

Authors:  Tzung-Dau Wang; Wen-Jone Chen; Tzan-Jr Mau; Jong-Wei Lin; Wan-Wan Lin; Yuan-Teh Lee
Journal:  Br J Pharmacol       Date:  2003-01       Impact factor: 8.739

Review 8.  Myocardial protection in man--from research concept to clinical practice.

Authors:  Dennis V Cokkinos; Costas Pantos
Journal:  Heart Fail Rev       Date:  2007-12       Impact factor: 4.214

9.  High plasma concentrations of asymmetric dimethylarginine inhibit ischemic cardioprotection in hypercholesterolemic rats.

Authors:  M B P Landim; P M M Dourado; A Casella-Filho; A C P Chagas; P L da-Luz
Journal:  Braz J Med Biol Res       Date:  2013-05-10       Impact factor: 2.590

10.  Genistein promotes endothelial colony-forming cell (ECFC) bioactivities and cardiac regeneration in myocardial infarction.

Authors:  Sang Hun Lee; Jun Hee Lee; Takayuki Asahara; Yong Sook Kim; Hae Chang Jeong; Youngkeun Ahn; Jin Sup Jung; Sang-Mo Kwon
Journal:  PLoS One       Date:  2014-05-15       Impact factor: 3.240

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.